Skip to main content

About the Author(s)


Johanna Catherine Maclean is an associate professor in the Economics Department at Temple University. She is an NBER research associate affiliated with the Health Economics Program. She is also a research affiliate at the Institute for Labor Economics. Her work focuses on behavioral health and health care, tobacco products, insurance, and public policies and economic factors related to these outcomes.

Maclean is a co-editor at the Journal of Policy Analysis and Management. She completed her PhD at Cornell University in 2012 after earning Bachelor's and Master's degrees at Dalhousie University in Canada. She has published over 50 articles in peer-reviewed journals, including the Journal of Health Economics, the Journal of Policy Analysis and Management, The Journal of Law & Economics, American Journal of Health Economics, Health Economics, Industrial and Labor Relations Review, Labour Economics, IZA Journal of Labor Policy, Industrial Relations, Health Affairs, and others. Her work has been supported by the National Institutes of Health, the Food and Drug Administration, the American Cancer Society, and the Robert Wood Johnson Foundation.



1. "Societal Burden of Substance Abuse," Caulkins J, Kasunic A, Lee M. International Public Health Journal 6(3), 2014, pp. 269–282. Go to ⤴︎
2. "Assessing the Economic Costs of Serious Mental Illness," Insel T. American Journal of Psychiatry 165(6), June 2008, pp. 663–665. Go to ⤴︎
3. Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health," Bose J, Hedden S, Lipari R, Park-Lee E. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD, 2018. Go to ⤴︎
4. "Drug Overdose Deaths in the United States, 1999–2017," Hedegaard H, Miniño A, Warner M. NCHS Data Brief 329, November 2018, National Center for Health Statistics.  Go to ⤴︎
5. Vietnam War Casualties (1955–1975). Military Factory, 2019.  Go to ⤴︎
6. "Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids," Alpert A, Powell D, Pacula R, NBER Working Paper 23031, January 2017, and American Economic Journal: Economic Policy 10(4), November 2018, pp. 1–35.  Go to ⤴︎
7. "How the Reformulation of OxyContin Ignited the Heroin Epidemic," Evans W, Lieber E, Power P. NBER Working Paper 24475, April 2018, and Review of Economics and Statistics 101(1), March 2019, pp. 1–15. Go to ⤴︎
8. "Behavioral Health in the Medicaid Program — People, Use, and Expenditures," Medicaid and CHIP Payment and Access Commission, Washington, DC, June 2015. Go to ⤴︎
9. "The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence from the Affordable Care Act," Maclean J, Saloner B. Journal of Policy Analysis and Management 38(2), Spring 2019, pp. 366–393. Go to ⤴︎
10. "The Affordable Care Act and Treatment for 'Substance Use Disorders:' Implications of Ending Segregated Behavioral Health Care," McLellan A, Woodworth A. Journal of Substance Abuse Treatment 46(5), May-June 2014; pp. 541–545. Go to ⤴︎
11. "Public Insurance and Psychotropic Prescription Medications for Mental Illness," Maclean J, Cook B, Carson J, Pesko M. NBER Working Paper 23760, March 2018, and B.E. Journal of Economics and Policy Analysis, 19(1), January 2019. Go to ⤴︎
12. "Public Insurance Expansions and Mental Healthcare Availability," Blunt E, Maclean J, Popovici I, Marcus S. Working paper in progress. Go to ⤴︎
13. "Losing Insurance and Behavioral Health Inpatient Care: Evidence from a large-scale Medicaid Disenrollment," Maclean J, Tello-Trillo S, Webber D. NBER Working Paper 25936, June 2019.  Go to ⤴︎
14. "Losing Public Health Insurance: TennCare Disenrollment and Personal Financial Distress," Argys L, Friedson A, Pitts M, Tello-Trillo S. Federal Reserve Bank of Atlanta Working Paper Series. Federal Reserve Bank of Atlanta, 2017. Go to ⤴︎
15. "Health Insurance Expansions and Providers' Behavior: Evidence from Substance-Use-Disorder Treatment Providers," Maclean J, Popovici I, Stern E. Journal of Law & Economics 61(2), 2018, pp. 279–310.  Go to ⤴︎
16. "Health Insurance and Traffic Fatalities: The Effects of Substance Use Disorder Parity Laws," Popovici I, Maclean J, French M. NBER Working Paper 23388, February 2018. Go to ⤴︎
17. "Access to Health Insurance and Utilization of Substance Use Disorder Treatment: Evidence from the Affordable Care Act Dependent Coverage Provision," Saloner B, Akosa Antwi Y, Maclean J, Cook B. Health Economics 27(1), January 2017, pp. 50–75.  Go to ⤴︎
18. "Substance Use Treatment Provider Behavior and Healthcare Reform: Evidence from Massachusetts," Maclean J, Saloner B. Health Economics 27(1), 2018, pp. 76–101. Go to ⤴︎

More from NBER

In addition to working papers, the NBER disseminates affiliates’ latest findings through a range of free periodicals — the NBER Reporter, the NBER Digest, the Bulletin on Retirement and Disability, the Bulletin on Health, and the Bulletin on Entrepreneurship — as well as online conference reports, video lectures, and interviews.

Gita Gopinath The 2022 Martin Feldstein Lecture: Managing a Turn in the Global Financial Cycle Primary tabs
  • Lecture
Gita Gopinath, the first deputy managing director of the International Monetary Fund, delivered the 2022 Martin...
 2022 Summer Institute Methods Lectures: Empirical Bayes Methods, Theory and Application image
  • Lecture
Large data sets that include observations on many workers at a given firm, multiple decisions by individual judges,...
Ben Bernanke, Douglas Diamond, and Philip Dybvig
  • Article
Former NBER research associate Ben Bernanke, current research associate Douglas Diamond, and Philip Dybvig have been awarded the 2022 Nobel Memorial...

NBER periodicals and newsletters are not copyrighted and may be reproduced freely with appropriate attribution.